It should also be taken into account that CD81/CD82 eGFP fusion proteins are regulated by the powerful CMV promoter, and that MM cells are already in a sensitised state of elevated protein synthesis and increased IRE/XBP1 expression. The gene discussed is CD82; the disease is Miyoshi myopathy.